Founded in 1997, Dechra Pharmaceutical Plc is a UK-based global specialist veterinary pharmaceuticals and related products business. It is engaged in developing, manufacturing, marketing and sales of high-quality veterinary products, with aims to sustainably improve animal health and welfare globally. The company is listed on the London Stock Exchange as LON: DPH and is a constituent of the FTSE 250 Index.
The company’s objective is to innovate, develop, manufacture, acquire, register and market products to the veterinary profession globally and provide technical support, high level of service and educational training to promote its brand. The company maintains strong relationship with veterinarians globally. The company has around 5388 products registered, with eight manufacturing sites and these products are distributed to 72 countries. The company offers four main product categories that include Companion Animal Products (CAP), Food Producing Animal Products (FAP), Equine and Nutrition. The Companion Animal Products (CAP) category offers a wide range of dermatology, analgesia and anaesthesia, endocrinology, cardiovascular, antibiotics and critical care products for dogs and cats. Its products include Vetoryl, Felimazole, Thyforon, SPECIFIC, Malaseb, Isaderm, Canaural, Cardisure and Comfortan, as well as our range of unlicensed ear cleaners, conditioners and shampoos. The Food producing Animal Products (FAP) offers a range of veterinary products to improve and maintain the health and welfare of pigs and poultry. It offers a superior range of water soluble antimicrobial treatments and its products include Octacillin, Soludex, Methoxasol, Cyclospray and Solustab. The Equine category offers locomotion, Anaesthesia, critical care, reproduction, dermatology and euthanasia products for horses and ponies. The Nutrition category offers diets for dogs and cats to support their wellbeing with various therapeutic conditions.
The company’s subsidiaries include Dechra veterinary products EU (DVP EU), Dechra Veterinary Products North America, Dechra Veterinary products International, Product Development and Regulatory Affairs and Dechra Pharmaceuticals Manufacturing.
24 Cheshire Avenue Cheshire Business Park, Lostock Gralam CW9 7UA United Kingdom